| Ident. | Authors (with country if any) | Title |
|---|
| 000108 (2021) |
Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon] | Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? |
| 000138 (2021) |
Katharina Habler [Allemagne] ; Mathias Brügel [Allemagne] ; Daniel Teupser [Allemagne] ; Uwe Liebchen [Allemagne] ; Christina Scharf [Allemagne] ; Ulf Schönermarck [Allemagne] ; Michael Vogeser [Allemagne] ; Michael Paal [Allemagne] | Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum. |
| 000302 (2021) |
Roberta Gagliardini [Italie] ; Alessandro Cozzi-Lepri [Royaume-Uni] ; Andrea Mariano [Italie] ; Fabrizio Taglietti [Italie] ; Alessandra Vergori [Italie] ; Amina Abdeddaim [Italie] ; Francesco Di Gennaro [Italie] ; Valentina Mazzotta [Italie] ; Alessandra Amendola [Italie] ; Giampiero D'Offizi [Italie] ; Fabrizio Palmieri [Italie] ; Luisa Marchioni [Italie] ; Pierluca Piselli [Italie] ; Chiara Agrati [Italie] ; Emanuele Nicastri [Italie] ; Maria Rosaria Capobianchi [Italie] ; Nicola Petrosillo [Italie] ; Giuseppe Ippolito [Italie] ; Francesco Vaia [Italie] ; Enrico Girardi [Italie] ; Andrea Antinori [Italie] | No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. |
| 000421 (2021) |
Elif Tanriverd [Turquie] ; Mustafa Çörtük [Turquie] ; Binnaz Zeynep Yildirim [Turquie] ; Efsun Gonca U Ur Chousein [Turquie] ; Demet Turan [Turquie] ; Halit Çinarka [Turquie] ; Mehmet Akif Özgül [Turquie] ; Erdo An Çetinkaya [Turquie] | Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data |
| 000548 (2021) |
Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. |
| 000594 (2021) |
Rahmet Guner [Turquie] ; Imran Hasanoglu [Turquie] ; Bircan Kayaaslan [Turquie] ; Adalet Aypak [Turquie] ; Esragul Akinci [Turquie] ; Hurrem Bodur [Turquie] ; Fatma Eser [Turquie] ; Ayse Kaya Kalem [Turquie] ; Orhan Kucuksahin [Turquie] ; Ihsan Ates [Turquie] ; Aliye Bastug [Turquie] ; Yasemin Tezer Tekce [Turquie] ; Zeynep Bilgic [Turquie] ; Fahriye Melis Gursoy [Turquie] ; Hatice Nisa Akca [Turquie] ; Seval Izdes [Turquie] ; Deniz Erdem [Turquie] ; Emra Asfuroglu [Turquie] ; Habibe Hezer [Turquie] ; Hatice Kilic [Turquie] ; Musa C Vak [Turquie] ; Sibel Aydogan [Turquie] ; Turan Buzgan [Turquie] | Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir. |
| 000604 (2021) |
Guillaume Hache [France] ; Jean Marc Rolain [France] ; Philippe Gautret [France] ; Jean-Claude Deharo [France] ; Philippe Brouqui [France] ; Didier Raoult [France] ; Stéphane Honoré [France] | Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. |
| 000743 (2021) |
Scott M. Vouri [États-Unis] ; Thuy N. Thai [États-Unis] ; Almut G. Winterstein [États-Unis] | An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic. |
| 000767 (2021) |
Yasemin Cag [Turquie] ; Sacit Icten [Turquie] ; Burcu Isik-Goren [Turquie] ; Naciye Betul Baysal [Turquie] ; Begum Bektas [Turquie] ; Ece Selvi [Turquie] ; Pinar Ergen [Turquie] ; Ozlem Aydin [Turquie] ; Ayse Canan Ucisik [Turquie] ; Fatma Yilmaz-Karadag [Turquie] ; Hulya Caskurlu [Turquie] ; Tulin Akarsu-Ayazoglu [Turquie] ; Hasan Kocoglu [Turquie] ; Sinan Uzman [Turquie] ; Muge Nural-Pamukcu [Turquie] ; Ferhat Arslan [Turquie] ; Gurhan Bas [Turquie] ; Mahmut Tayyar Kalcioglu [Turquie] ; Haluk Vahaboglu [Turquie] | A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort. |
| 000A65 (2020) |
Manoon Surabotsophon ; Yingyot Klai-On ; Vipa Thanachartwet ; Sirote Khunapornphairote ; Supat Chamnanchanunt ; Theerapat Racharak ; Wannada Laisuan ; Duangjai Sahassananda ; Samlee Hapunna ; Somjit Jinapuk ; Suthee Leelasetakul ; Varunee Desakorn | Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series. |
| 000B52 (2020) |
Eoin Feeney [Irlande (pays)] ; Deborah Wallace [Irlande (pays)] ; Aoife Cotter [Irlande (pays)] ; Willard Tinago [Irlande (pays)] ; Cormac Mccarthy [Irlande (pays)] ; David Keane [Irlande (pays)] ; Rabia Hussain [Irlande (pays)] ; Elena Alvarez Barco [Irlande (pays)] ; Peter Doran [Irlande (pays)] ; Patrick Mallon [Irlande (pays)] | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. |
| 000B59 (2020) |
Siri Göpel [Allemagne] ; Wolfgang Bethge [Allemagne] ; Peter Martus [Allemagne] ; Florian Kreth [Allemagne] ; Thomas Iftner [Allemagne] ; Stefanie Joos [Allemagne] ; Stefanie Döbele [Allemagne] ; Benjamin Mordmüller [Allemagne] ; Peter Kremsner [Allemagne] ; Thomas Ettrich [Allemagne] ; Thomas Seufferlein [Allemagne] ; Michael Bitzer [Allemagne] ; Nisar Malek [Allemagne] | Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. |
| 001156 (2020) |
Bharath Kumar Tirupakuzhi Vijayaraghavan [Inde] ; Vivekanand Jha [Inde, Royaume-Uni] ; Dorrilyn Rajbhandari [Australie] ; Sheila Nainan Myatra [Inde] ; Oommen John [Inde] ; Arpita Ghosh [Inde] ; Abhinav Bassi [Inde] ; Sumaiya Arfin [Inde] ; Mallikarjuna Kunigari [Inde] ; Rohina Joshi [Inde, Australie] ; Lachlan Donaldson [Australie] ; Naomi Hammond [Australie] ; Balasubramanian Venkatesh [Australie] | Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial. |
| 001360 (2020) |
Abdulmecit Afsin [Turquie] ; Kenan Ecemis [Turquie] ; Ramazan Asoglu [Turquie] | Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19. |
| 001534 (2020) |
Hamid Rahmani [Iran] ; Effat Davoudi-Monfared [Iran] ; Anahid Nourian [Iran] ; Morteza Nabiee [Iran] ; Setayesh Sadeghi [Iran] ; Hossein Khalili [Iran] ; Ladan Abbasian [Iran] ; Fereshteh Ghiasvand [Iran] ; Arash Seifi [Iran] ; Malihe Hasannezhad [Iran] ; Sara Ghaderkhani [Iran] ; Mostafa Mohammadi [Iran] ; Mir Saeed Yekaninejad [Iran] | Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. |
| 001747 (2020) |
Roland Derwand [Allemagne] ; Martin Scholz [Allemagne] ; Vladimir Zelenko [États-Unis] | COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study. |
